These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16385349)

  • 1. [Effects of TNF antagonists on immune and neuroendocrine system].
    Valesini G; Cutolo M
    Reumatismo; 2005; 57(4 Suppl):3-7. PubMed ID: 16385349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are there differences among anti-TNFα biological drugs?].
    Valesini G
    Reumatismo; 2005; 57(4 Suppl):1-2. PubMed ID: 16385348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Approved indications and other possible utilizations of anti-TNFα biologic drugs].
    Grassi W; Montecucco C
    Reumatismo; 2005; 57(4 Suppl):30-3. PubMed ID: 16385353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases].
    Lapadula G
    Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differences in pharmacology of tumor necrosis factor (TNF) antagonists].
    Fiocco U; Bombardieri S
    Reumatismo; 2005; 57(4 Suppl):8-16. PubMed ID: 16385350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety of anti-TNFα biological drugs].
    Trotta F; Valentini G
    Reumatismo; 2005; 57(4 Suppl):34-9. PubMed ID: 16385354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.
    Collamer AN; Battafarano DF
    Semin Arthritis Rheum; 2010 Dec; 40(3):233-40. PubMed ID: 20580412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitors of TNFalpha].
    Brousse C
    Rev Med Interne; 2003 Feb; 24(2):123-6. PubMed ID: 12650894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TNF targetting therapy for rheumatoid arthritis].
    Takeuchi T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1787-94. PubMed ID: 17037316
    [No Abstract]   [Full Text] [Related]  

  • 10. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?
    Rigby WF
    Nat Clin Pract Rheumatol; 2007 Apr; 3(4):227-33. PubMed ID: 17396108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of spondyloarthritides with anti-TNFalpha biologic agents.
    Braun J
    Reumatismo; 2006; 58 Spec No.1():71-2. PubMed ID: 23631067
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic management of plaque psoriasis: the interest of anti-TNFalpha].
    Ortonne JP
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 2):4S6-4S9. PubMed ID: 16335346
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and clinical effects of anti-TNFalpha treatment.
    Valesini G; Iannuccelli C; Marocchi E; Pascoli L; Scalzi V; Di Franco M
    Autoimmun Rev; 2007 Nov; 7(1):35-41. PubMed ID: 17967723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of TNF-α inhibitors in systemic sclerosis.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Puppo F
    Immunotherapy; 2014; 6(3):283-9. PubMed ID: 24762073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 19. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
    Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P
    Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.